Atlas Trials

Plasma miRNAs Predict Radiosensitivity of Different Fractionation Regimes in Palliative Radiotherapy for Advanced Non-small Cell Lung Cancer:Multicenter Controlled Study.(RadmiR-01)

Clinical trial NCT03074175 · COMPLETED

Trial details

NCT number
NCT03074175
Sponsor
Xinqiao Hospital of Chongqing
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Advanced Nsclc
Start date
2017-07-01
Primary completion
2019-08-01
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.